<?xml version="1.0" encoding="UTF-8"?>
<results title="disease">
 <result pre="conditions [ 17], [ 18], autoimmune disorders [ 19]–[ 21]," exact="oral cancer" post="[ 22], tuberculosis [ 23], and malaria [ 24]."/>
 <result pre="[ 17], [ 18], autoimmune disorders [ 19]–[ 21], oral" exact="cancer" post="[ 22], tuberculosis [ 23], and malaria [ 24]."/>
 <result pre="18], autoimmune disorders [ 19]–[ 21], oral cancer [ 22]," exact="tuberculosis" post="[ 23], and malaria [ 24]. As a common"/>
 <result pre="19]–[ 21], oral cancer [ 22], tuberculosis [ 23], and" exact="malaria" post="[ 24]. As a common characteristic, OAS has been"/>
 <result pre="contribute with resistance to the only approved treatment for gastric" exact="cancer" post="[ 25] and oncolytic virus therapies for pancreatic ductal"/>
 <result pre="virus therapies for pancreatic ductal adenocarcinoma (PDA) [ 26]. In" exact="oral cancer," post="it has been demonstrated that high expression of OAS2"/>
 <result pre="chain expression have also shown up-regulation of OAS genes. In" exact="systemic lupus erythematosus" post="(SLE), an autoimmune disorder related to the deficiency of"/>
 <result pre="expression have also shown up-regulation of OAS genes. In systemic" exact="lupus erythematosus" post="(SLE), an autoimmune disorder related to the deficiency of"/>
 <result pre="clinical parameters, the up-regulation of OAS was observed in relapsing-remitting" exact="multiple sclerosis" post="[ 28] and systemic sclerosis [ 29]. In pancreatic"/>
 <result pre="expression has been reported as a signature that differentiates active" exact="tuberculosis" post="from latent tuberculosis. As a consequence, it has been"/>
 <result pre="[ 23]. Similarly, the analysis of the OAS role during" exact="malaria" post="infections has demonstrated that deficient suppression of type I"/>
 <result pre="the OAS role during malaria infections has demonstrated that deficient" exact="suppression" post="of type I IFN signaling may promote severe infections"/>
 <result pre="of immunoregulatory functions, promoting the progression of diseases such as" exact="cancer" post="[ 22], autoimmune and autoinflammatory disorders [ 17]–[ 21],"/>
 <result pre="Prans , and K. Abram , &quot; Transcriptional landscape of" exact="psoriasis" post="identifies the involvement of IL36 and IL36RN,&quot; BMC Genomics,"/>
 <result pre="of increased interferon-inducible gene expression with disease activity and lupus" exact="nephritis" post="in patients with systemic lupus erythematosus,&quot; Arthritis Rheum., vol."/>
 <result pre="R. Shah , and E. Hastie , &quot; Resistance of" exact="pancreatic cancer" post="cells to oncolytic vesicular stomatitis virus: Role of type"/>
 <result pre="Shah , and E. Hastie , &quot; Resistance of pancreatic" exact="cancer" post="cells to oncolytic vesicular stomatitis virus: Role of type"/>
 <result pre=", &quot; Resistance of pancreatic cancer cells to oncolytic vesicular" exact="stomatitis" post="virus: Role of type I interferon signaling,&quot; Virology, vol."/>
 <result pre="G. M. van Baarsen et al., &quot; A subtype of" exact="multiple sclerosis" post="defined by an activated immune defense program,&quot; Genes Immun.,"/>
</results>
